We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Halyard Health, Inc. (delisted) | NYSE:HYH | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.25 | 0.00 | 01:00:00 |
ALPHARETTA, Ga., April 26, 2017 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) today announced that Robert Abernathy, chairman and chief executive officer, will present at the Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3 at approximately 10 a.m. ET at the InterContinental Hotel in Boston.
A webcast of the conference presentation will be available on the Investors section of the Halyard Health website at https://halyardhealth.investorroom.com/ and will be archived on that site.
About Halyard Health:
Halyard Health (NYSE: HYH) is a medical technology company focused on eliminating pain, speeding recovery and preventing infection for healthcare providers and their patients. Headquartered in Alpharetta, Georgia, Halyard is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery and preventing healthcare-associated infections. Halyard's business segments - Medical Devices and Surgical and Infection Prevention (S&IP) - develop, manufacture and market clinically superior solutions that improve medical outcomes and business performance in more than 100 countries. For more information, visit www.halyardhealth.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/halyard-health-inc-to-present-at-deutsche-bank-health-care-conference-300445470.html
SOURCE Halyard Health, Inc.
Copyright 2017 PR Newswire
1 Year Halyard Health Chart |
1 Month Halyard Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions